Tomiyuki Sugi

3PUBLICATIONS
0CO-AUTHORS
Medical infection agents (incl. prions)Medical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 17, 2026
Clinical characteristics and risk factors for pomalidomide-induced skin rash: Implications for pharmacist-led monitoring in real-world multiple myeloma care.

|Nov 15, 2021
Preceding bortezomib administration for a certain period reduces the risk of lenalidomide-induced skin rash.

Tomiyuki Sugi, Mitsuo Mita, Takeo Yasu

|May 07, 2021
Simple desensitization protocol for multiple myeloma patients with lenalidomide-induced skin rash: Case series.

Tomiyuki Sugi, Mitsuo Mita, Takeo Yasu

Pageof 1

Frequent Collaborators